Back | Next |
home / stock / srdx / srdx message board
Subject | By | Source | When |
---|---|---|---|
Thanks, Aslan. I posted the full text of | DewDiligence | investorshub | 05/26/2011 8:49:41 PM |
Re: FWIW (ART bioresorbable DES) | aslan2772 | investorshub | 05/26/2011 7:45:49 PM |
FWIW: | DewDiligence | investorshub | 05/17/2011 6:12:58 PM |
FP, thanks for your reply. The Johns Hopkins/Medicare | DewDiligence | investorshub | 05/16/2011 10:04:06 AM |
I don't follow Lucentis / Avastin so my | foolishpremise | investorshub | 05/05/2011 5:43:39 PM |
Roger thatI wasn't sure if there had been | DewDiligence | investorshub | 04/28/2011 9:50:03 PM |
Re: Long-acting Lucentis Formulation - probably not... | Democritus_of_Abdera | investorshub | 04/28/2011 9:42:57 PM |
Is$ SRDX still working on a long-acting formulation | DewDiligence | investorshub | 04/28/2011 9:37:15 PM |
Re: Surprising Response to Yesterdays Q2 CC/Earnings... | Democritus_of_Abdera | investorshub | 04/28/2011 9:29:48 PM |
Wow, I listened to the conference call and | skiplarson98 | investorshub | 04/28/2011 4:23:58 PM |
Simply stated by Aslan, Gary was a breath | skiplarson98 | investorshub | 04/28/2011 4:09:57 PM |
Plavix PCI Study Shows 6-Months Non-Inferior to 12: | DewDiligence | investorshub | 04/06/2011 8:19:49 PM |
SRDXs Q1 2011 CC... | Democritus_of_Abdera | investorshub | 01/31/2011 10:27:42 AM |
re: accounting | aslan2772 | investorshub | 01/27/2011 6:54:55 AM |
$SRDX is resorting to more and more non-GAAP | DewDiligence | investorshub | 01/27/2011 12:47:01 AM |
First bioabsorbable stent approved in Europe | bridgeofsighs | investorshub | 01/10/2011 6:38:11 PM |
I had not planned on going this year, | skiplarson98 | investorshub | 01/07/2011 7:38:52 AM |
Ouch...nice catch. | foolishpremise | investorshub | 01/06/2011 10:01:28 PM |
Re Annual Mtg on Feb 7... | Democritus_of_Abdera | investorshub | 01/06/2011 10:34:47 AM |
Re: Sale of Pharmaceutical Division... | Democritus_of_Abdera | investorshub | 12/16/2010 5:35:56 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Surmodics, Inc. (NASDAQ:SRDX)'s sale ...
Access to Premier’s healthcare group purchasing organization (GPO) expected to expand national market reach for Surmodics endovascular thrombectomy solutions. Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announce...
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Stericycle, Inc. (NASDAQ:SRCL)'s sale...